Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy

被引：48
|
作者：
Wang, Xiaofei [1 ]
Zhou, Ling [1 ]
Yin, Jiani C. [2 ]
Wu, Xue [3 ]
Shao, Yang W. [3 ,4 ]
Gao, Beili [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Resp Dis & Crit Care Med, 197 Rui Jin Er Rd, Shanghai 200025, Peoples R China
[2] Nanjing Geneseeq Technol Inc, Med Dept, Nanjing, Jiangsu, Peoples R China
[3] Geneseeq Technol Inc, Translat Med Res Inst, Toronto, ON, Canada
[4] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 05期
基金：
中国国家自然科学基金;
关键词：
C797S; OSIMERTINIB; T790M; AZD9291;
D O I：
10.1016/j.jtho.2019.01.015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E85 / E88
页数：4
相关论文
共 50 条
  • [1] Lung Adenocarcinoma Harboring EGFR-19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy
    Wang, X.
    Gao, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S922 - S923
  • [2] Effective clinical response of lung adenocarcinoma harboring EGFR 19Del/T790M/in cis-C797S osimertinib to osimertinib and gefitinib combination therapy
    Wang, Yanyan
    Jiang, Chenchen
    Tang, Mingyue
    Li, Huiyuan
    Zhao, Cancan
    Zhao, Menglin
    Zhang, Yue
    Li, Xinwei
    Mi, Jiaqi
    Shen, Honghong
    Wang, Zishu
    Su, Fang
    [J]. QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (08) : 5362 - 5368
  • [3] Overcoming the C797S/T790M mutation mediated Osimertinib resistance by Brigatinib combined with anti-EGFR antibody.
    Uchibori, Ken
    Fujita, Naoya
    Katayama, Ryohei
    [J]. CANCER SCIENCE, 2018, 109 : 568 - 568
  • [4] Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy
    Wang, Yubo
    Yang, Nong
    Zhang, Yongchang
    Li, Li
    Han, Rui
    Zhu, Mengxiao
    Feng, Mingxia
    Chen, Hengyi
    Lizaso, Analyn
    Qin, Tian
    Liu, Xiaoyan
    He, Yong
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (08) : 1369 - 1375
  • [5] Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First- and Third-Generation EGFR TKIs and Shifts Allelic Configuration at Resistance
    Wang, Zhen
    Yang, Jin-Ji
    Huang, Jie
    Ye, Jun-Yi
    Zhang, Xu-Chao
    Tu, Hai-Yan
    Han-Zhang, Han
    Wu, Yi-Long
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : 1723 - 1727
  • [6] Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors
    Zhou, Zhen
    Zhao, Yi
    Shen, Shengping
    Gu, Linping
    Niu, Xiaomin
    Xu, Yunhua
    Zhang, Tengfei
    Xiang, Jianxing
    Mao, Xinru
    Lu, Shun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) : E157 - E159
  • [7] EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib
    Kobayashi, Yoshihisa
    Fujino, Toshio
    Nishino, Masaya
    Koga, Takamasa
    Chiba, Masato
    Sesumi, Yuichi
    Ohara, Shuta
    Shimoji, Masaki
    Tomizawa, Kenji
    Takemoto, Toshiki
    Mitsudomi, Tetsuya
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (05) : 727 - 731
  • [8] Structural pharmacological studies on EGFR T790M/C797S
    Kong, Lu-Lu
    Ma, Rui
    Yao, Ming-Yu
    Yan, Xiao-E.
    Zhu, Su-Jie
    Zhao, Peng
    Yun, Cai-Hong
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 488 (02) : 266 - 272
  • [9] Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report
    Zhao, Jing
    Zou, Ming
    Lv, Jinyan
    Han, Yingmin
    Wang, Guangzhi
    Wang, Gang
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 5545 - 5550
  • [10] Stevens-Johnson syndrome induced by toripalimab in a previously EGFR-TKI-treated advanced lung adenocarcinoma patient harboring EGFR mutations 19 del/T790M/C797S in trans and cis: a case report
    Chen, Yang
    Hong, Hanhan
    Bao, Shujun
    Tang, Hao
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
12345